Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+15.6%
5Y CAGR+44.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+15.6%/yr
Annual compound
5Y CAGR
+44.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.3x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $173.70M | +16.9% |
| 2024 | $148.61M | +8.4% |
| 2023 | $137.09M | +22.0% |
| 2022 | $112.38M | +54.2% |
| 2021 | $72.88M | +165.3% |
| 2020 | $27.47M | +243.7% |
| 2019 | $7.99M | - |